A formal analysis of cytokine networks in chronic fatigue syndrome
- PMID: 20447453
- PMCID: PMC2939140
- DOI: 10.1016/j.bbi.2010.04.012
A formal analysis of cytokine networks in chronic fatigue syndrome
Abstract
Chronic Fatigue Syndrome (CFS) is a complex illness affecting 4 million Americans for which no characteristic lesion has been identified. Instead of searching for a deficiency in any single marker, we propose that CFS is associated with a profound imbalance in the regulation of immune function forcing a departure from standard pre-programmed responses. To identify these imbalances we apply network analysis to the co-expression of 16 cytokines in CFS subjects and healthy controls. Concentrations of IL-1a, 1b, 2, 4, 5, 6, 8, 10, 12, 13, 15, 17 and 23, IFN-γ, lymphotoxin-α (LT-α) and TNF-α were measured in the plasma of 40 female CFS and 59 case-matched controls. Cytokine co-expression networks were constructed from the pair-wise mutual information (MI) patterns found within each subject group. These networks differed in topology significantly more than expected by chance with the CFS network being more hub-like in design. Analysis of local modularity isolated statistically distinct cytokine communities recognizable as pre-programmed immune functional components. These showed highly attenuated Th1 and Th17 immune responses in CFS. High Th2 marker expression but weak interaction patterns pointed to an established Th2 inflammatory milieu. Similarly, altered associations in CFS provided indirect evidence of diminished NK cell responsiveness to IL-12 and LT-α stimulus. These observations are consistent with several processes active in latent viral infection and would not have been uncovered by assessing marker expression alone. Furthermore this analysis identifies key sub-networks such as IL-2:IFN-γ:TNF-α that might be targeted in restoring normal immune function.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al.Brain Behav Immun. 2010 Oct;24(7):1218; author reply 1219. doi: 10.1016/j.bbi.2010.06.004. Epub 2010 Jun 16. Brain Behav Immun. 2010. PMID: 20561580 No abstract available.
References
-
- Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature. 1985;318(6047):665–667. - PubMed
-
- Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4Tcell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910–1914. - PubMed
-
- Airoldi I, Guglielmino R, Carra G, Corcione A, Gerosa F, Taborelli G, Trinchieri G, Pistoia V. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica. 2002;87(4):434–442. Review. - PubMed
-
- Barabási AL. Network medicine - from obesity to the “diseasome”. N Engl J Med. 2007;357(4):404–407. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
